Tailor-made Pharma Solutions l Pharma Intelligence

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Commercial Success

Clinical Planning

Patient Engagement & Recruitment

Regulatory & Compliance

Conferences 2022

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

Scrip

Z-AT-ut6

19 Jun 2023

Non vero eos nulla quia et sint mollitia quia rerum et voluptatem sit ut error aliquam fugit dolorem sed accusamus sapiente earum tenetur iure.

Topic test-tag

View article
Scrip

Z-AT-id0

26 May 2023

Numquam aspernatur quos dolores qui voluptas et aut autem doloribus dolor dignissimos facere fugit sint possimus porro repudiandae velit eos.

Topic test-tag

View article
Scrip

Z-AT-qui8

25 May 2023

Vitae non sint omnis id est est voluptatibus laborum odio sunt recusandae itaque quas rem harum necessitatibus iste a porro incidunt dolores.

Topic test-tag

View article
Scrip

Z-AT-voluptatem3

19 May 2023

Deleniti earum ut aut nam dolor quidem ut accusamus et sed sunt quasi minima dolore et enim ipsum molestias cum maiores similique.

Topic test-tag

View article
Scrip

Z-AT-beatae19

19 May 2023

Rerum molestiae quisquam numquam cupiditate id dolor tempore non debitis nam maiores distinctio consequatur architecto qui maiores beatae aut eius praesentium quia accusamus.

Topic test-tag

View article
Scrip

Z-AT-odit4

19 May 2023

Laudantium sequi quo architecto quisquam iure in numquam saepe beatae voluptatem voluptate totam nisi aut reprehenderit officiis modi ut non voluptatem dolores optio suscipit ad.

Topic test-tag

View article
Scrip

Z-AT-dolore10

27 Apr 2023

Nesciunt alias eum ad laboriosam ea voluptatem quasi rerum cupiditate et vitae blanditiis et autem consequatur labore a sit voluptas repudiandae nostrum aut.

Topic test-tag

View article
Scrip

Z-AT-quibusdam17

27 Apr 2023

Aut perferendis dolorum dolores ullam iusto qui dicta est deleniti at laborum fuga est earum rerum harum et neque totam dicta.

Topic test-tag

View article
TrialScope Atlas

Test3-1popup

10 Jan 2023

Topic Account Based Marketing

View article
TrialScope Atlas

Test5-2popups2

10 Jan 2023

Topic Account Based Marketing

View article
TrialScope Atlas

Test2-0popups

10 Jan 2023

Topic Account Based Marketing

View article
TrialScope Atlas

Test1-2popups

10 Jan 2023

Topic Account Based Marketing

View article
TrialScope Atlas

Test4-1popup2

10 Jan 2023

Topic Account Based Marketing

View article
Scrip

Opdivos EU Colorectal Cancer is a Setback but More Than Offset By Potential Gains

By Ian Schofield 29 Nov 2022

Bristol-Myers Squibb has withdrawn its EU application to extend Opdivo’s use to metastatic colorectal cancer (mCRC), following a similar move for liver cancer last year. But the mCRC withdrawal is likely to have limited commercial impact and the company is more interested in pursuing the product’s use in combination treatment for this indication.

Topic Cancer

View article
Trial Results Summaries

AstraZeneca takes an innovative approach to trial results summaries

25 Nov 2022

What Are Trial Results Summaries and Why Are They Necessary?

Topic Clinical Trials

View case study

Latest headlines

Scrip

22 Sep 2023

Infographic: A Snapshot Of Non-Alcoholic Steatohepatitis R&D

Link
Scrip

22 Sep 2023

A Look Into The Future Of NASH

Link
HBW Insight

22 Sep 2023

Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement

Link
Medtech Insight

22 Sep 2023

Q&A: Allyson Mullen On ‘Uncharted Waters’ Of Breakthrough Pathway

Link
Scrip

22 Sep 2023

Executives On The Move: C-Suite Changes At ImmunoGen, Kronos Bio, Verve Therapeutics And More

Link
Pink Sheet

22 Sep 2023

EU Could Soon Have Three XBB.1.5 COVID-19 Vaccines For Winter Season

Link
Scrip

22 Sep 2023

Promising Early Results For AZ And Daiichi’s Dato-DXd In Breast Cancer – But How Soon Can They File?

Link
Scrip

22 Sep 2023

BenevolentAI Still Bullish As CEO Shields Steps Down

Link
Pink Sheet

22 Sep 2023

EU Orphan Drug Law Reform Will See Innovation Drop By 12%, Industry Warns

Link
Generics Bulletin

22 Sep 2023

BioFactura Completes Phase I For Late-To-Market Stelara Biosimilar

Link
HBW Insight

22 Sep 2023

MacuHealth Asserts ‘Rigorous Process’ In Research Supporting Claims, But No Bill Of Health From NAD

Link
Scrip

22 Sep 2023

Glenmark Divests API Company, Setting Out On Distinct Journeys

Link
Medtech Insight

22 Sep 2023

Postmarket Surveillance Continues To Challenge AI/ML Device Regulators

Link
Pink Sheet

21 Sep 2023

EU CHMP Opinions And MAA Updates

Link
Scrip

21 Sep 2023

Genentech Joins Hunt For ‘Molecular Glue’ Drugs With Orionis

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Speak to Sales

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact Sales

Client Services

US Toll-Free : +1 888 670 8900
US Toll : +1 212-600-3520
UK & Europe : +44 (0) 208 052 0700

Contact Customer Services

Pharma Report Store

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now

Tailor-made Pharma Solutions

Tailor-made solutions

Pharma Intelligence latest insights

Z-AT-ut6

Z-AT-id0

Z-AT-qui8

Z-AT-voluptatem3

Z-AT-beatae19

Z-AT-odit4

Z-AT-dolore10

Z-AT-quibusdam17

Test3-1popup

Test5-2popups2

Test2-0popups

Test1-2popups

Test4-1popup2

Opdivos EU Colorectal Cancer is a Setback but More Than Offset By Potential Gains

AstraZeneca takes an innovative approach to trial results summaries

Latest headlines

Infographic: A Snapshot Of Non-Alcoholic Steatohepatitis R&D

A Look Into The Future Of NASH

Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement

Q&A: Allyson Mullen On ‘Uncharted Waters’ Of Breakthrough Pathway

Executives On The Move: C-Suite Changes At ImmunoGen, Kronos Bio, Verve Therapeutics And More

EU Could Soon Have Three XBB.1.5 COVID-19 Vaccines For Winter Season

Promising Early Results For AZ And Daiichi’s Dato-DXd In Breast Cancer – But How Soon Can They File?

BenevolentAI Still Bullish As CEO Shields Steps Down

EU Orphan Drug Law Reform Will See Innovation Drop By 12%, Industry Warns

BioFactura Completes Phase I For Late-To-Market Stelara Biosimilar

MacuHealth Asserts ‘Rigorous Process’ In Research Supporting Claims, But No Bill Of Health From NAD

Glenmark Divests API Company, Setting Out On Distinct Journeys

Postmarket Surveillance Continues To Challenge AI/ML Device Regulators

EU CHMP Opinions And MAA Updates

Genentech Joins Hunt For ‘Molecular Glue’ Drugs With Orionis

Next steps

This is Contactus Section

Request a live demo

Speak to Sales

Client Services

Pharma Report Store